KS HB2694

Establishes the "Opioid Patients Right to Know Act" in Kansas, requiring prescribers to discuss risks with patients (or parents of minor patients) before issuing an initial prescription for a Schedule II controlled substance or any other opioid pain reliever for acute or chronic pain

Required discussion topics include the risk of addiction and overdose, dangers of combining opioids with alcohol, benzodiazepines, or other central nervous system depressants, the reason the prescription is necessary, available alternative treatments, and general risks of the prescribed drugs

Prescribers must document in the patient's medical record that the discussion about risks of physical or psychological dependence and the availability of alternative treatments took place

Exempts patients currently in cancer treatment, those receiving hospice or palliative care, residents of long-term healthcare facilities, and patients being prescribed medications for substance abuse or opioid dependence treatment

Takes effect upon publication in the Kansas statute book